Table 2 Vaccines being used against bovine viral diarrhoea virus (BVDV) at the time of the survey and the number of times these vaccines were mentioned by practitioners (n = 124) in a survey of BNP in 2010
From: Spatial distribution and incidence of bovine neonatal pancytopenia in Bavaria, Germany
Vaccine Name | Number times mentioned in total | Number times mentioned by 42 veterinary practices with observed BNP cases | Number times mentioned by 82 veterinary practices without observed BNP cases |
|---|---|---|---|
Bovidec® (Virbac) | 52 (28%) | 13 (19%) | 39 (33%) |
Bovilis®BVD (Intervet) | 36 (19%) | 12 (17%) | 24 (21%) |
Vacoviron® (Merial) | 35 (19%) | 10 (15%) | 25 (21%) |
PregSure®BVD (Pfizer) | 34 (18%) | 25 (36%) | 9 (8%) |
Mucobovin® (Merial) | 26 (14%) | 7 (10%) | 19 (16%) |
Rispoval 3-BRSV-PI3-BVD® (Pfizer) | 3 (2%) | 2 (3%) | 1 (1%) |
Total number of declarations | 186 (100%) | 69 (100%) | 117 (100%) |